H.R.3254 - Heroin and Opioid Abuse Prevention and Treatment Act of 2017115th Congress (2017-2018) |
|Sponsor:||Rep. Lujan Grisham, Michelle [D-NM-1] (Introduced 07/14/2017)|
|Committees:||House - Ways and Means; Energy and Commerce; Budget|
|Latest Action:||House - 07/14/2017 Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.3254 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (07/14/2017)
Heroin and Opioid Abuse Prevention and Treatment Act of 2017
This bill amends the Internal Revenue Code to require manufacturers, producers, and importers of active opioids to pay an excise tax of one cent per milligram of opioid.
The bill also amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to provide grants to states for: (1) research on opioids (including heroin), and (2) opioid abuse prevention and treatment.
The Department of the Treasury must transfer an amount equal to the revenue collected from the tax to HHS to carry out this bill. The bill makes the funds available without further appropriation and designates the funding as an emergency requirement under the Statutory Pay-As-You-Go Act of 2010 (PAYGO).